Ardent Health, a hospital operator, is showing signs that its long-running battle with high labor costs is turning a corner. In the third quarter, salaries, wages, and benefits fell 4.3% year over year, according to RBC Capital Markets, which lifted its price target on the stock to $18 from $13 and reiterated an outperform rating.
For hospital companies, labor is typically the single largest expense, often eating up close to half of every dollar of revenue. So even a small improvement in that ratio can have an outsized effect on profitability. RBC noted that Ardent's labor costs dropped to 39.9% of revenue, a 300-basis-point improvement from a year earlier. A basis point is one-hundredth of a percentage point, so that's a three-percentage-point swing.
Contract labor: the big driver
The biggest factor behind the improvement appears to be a sharp reduction in contract labor. RBC estimates that contract labor—temporary staff hired through agencies, often at premium rates—fell 45% and now makes up just 2% of Ardent's total salaries, wages, and benefits. That's a meaningful shift because temporary workers are typically much more expensive than permanent employees and can be brought in on short notice, making costs harder to predict.
Management said faster hiring and greater staffing stability should help these gains stick. If that holds, it would mark a departure from the pandemic-era crunch, when hospitals across the country struggled to find nurses and other staff, driving up wages and forcing heavy reliance on costly contract labor. As that pressure has eased, operators like Ardent have been able to rebuild margins.
Professional fees—payments to doctors and other outside providers—have also cooled over the course of the year, according to RBC, adding to the cost relief.
What it means for investors
For investors, the key takeaway is that Ardent's cost base is becoming more predictable. When labor runs close to 40% of revenue, a 300-basis-point improvement can expand margins even if revenue growth is only modest, because more of each new dollar of sales flows through to profit. The mix shift away from contract labor also reduces quarter-to-quarter volatility, since temporary staffing costs can swing wildly depending on demand and availability.
That combination can lower the perceived "execution risk" in valuation models. Instead of focusing on a one-off quarterly beat, investors can start to assess whether Ardent can reliably deliver the kind of earnings growth RBC is now projecting. The firm raised its adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) forecasts to $518.3 million for 2026 and $523.7 million for 2027.
Adjusted EBITDA is a common profitability measure that strips out financing and accounting costs, giving a clearer picture of a company's operational performance. RBC's higher forecasts suggest it sees the labor-cost improvement as durable, not just a lucky quarter.
Still, investors should keep in mind that hospital operators face other pressures. Reimbursement rates from insurers and government programs, patient volumes, and the broader economy all play a role. And while labor costs are easing, they remain a large and sensitive line item. Any reversal—say, a new wave of staffing shortages or a spike in contract labor demand—could quickly erode the gains.
For now, the market is reacting positively to the news, with RBC's price target hike signaling confidence. The stock's valuation will likely hinge on whether Ardent can continue to deliver on the cost front while also growing revenue. As with any investment, it's worth watching how the company executes in the coming quarters rather than reading too much into a single quarter's improvement.
For context, other companies have also been navigating cost pressures. Humana recently raised its profit forecast as medical costs eased, a similar theme of cost relief boosting outlooks. And in the broader market, healthcare and tech helped lift Canada's TSX despite weak jobs data, showing how sector-specific trends can diverge from the macro picture.
Ultimately, Ardent's story is a reminder that in capital-intensive industries like healthcare, controlling costs can be just as important as growing revenue. For everyday investors, the takeaway is to look beyond the headline numbers and understand what's driving the change—in this case, a meaningful reduction in expensive temporary labor that could support profits for years to come.
